These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5074533)

  • 41. Biliary and urinary excretion of [14C]warfarin in rabbits.
    Wong LT; Solomonraj G
    Xenobiotica; 1980 Mar; 10(3):201-10. PubMed ID: 7467404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biliary excretion of 3-methylcholanthrene as controlled by its metabolism.
    Levine WG
    J Pharmacol Exp Ther; 1972 Nov; 183(2):420-6. PubMed ID: 5083554
    [No Abstract]   [Full Text] [Related]  

  • 43. Multimodal distribution of warfarin binding to protein in serum of male-Sprague Dawley rats.
    Slattery JT; Yacobi A; Levy G
    Life Sci; 1976 Aug; 19(3):447-51. PubMed ID: 957882
    [No Abstract]   [Full Text] [Related]  

  • 44. Warfarin binding to plasma of workers exposed to toluene diisocyanate.
    Bachmann K; Shapiro R; Forney RB
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):47-50. PubMed ID: 6277811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interactions between different bile salts in the biliary excretion of the rat.
    Kitani K; Kanai S
    Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):139-52. PubMed ID: 6844732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein binding of warfarin.
    Levy G
    Br J Clin Pharmacol; 1995 Feb; 39(2):211. PubMed ID: 7742167
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pharmacokinetic studies on 14 C-labelled penicillamine].
    Planas-Bohne F
    Arzneimittelforschung; 1972 Sep; 22(9):1426-33. PubMed ID: 4678603
    [No Abstract]   [Full Text] [Related]  

  • 48. Studies of the possible therapeutic interaction between cyclamate and warfarin.
    Holcenberg JS; Bidgood M; Dixon RL
    Curr Ther Res Clin Exp; 1969 Sep; 11(9):577-84. PubMed ID: 4980888
    [No Abstract]   [Full Text] [Related]  

  • 49. The effect of oxyphenbutazone on partial thromboplastin time and lack of effect on Hageman factor in guinea pigs.
    Weiner M
    J Med; 1971; 2(2):120-5. PubMed ID: 5286513
    [No Abstract]   [Full Text] [Related]  

  • 50. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Drug content study of human saliva, bile and cerebrospinal fluid].
    Scherber A; Feller K; Terhaag B; Le Petit G; Richter K
    Farmakol Toksikol; 1982; 45(5):106-7. PubMed ID: 7140946
    [No Abstract]   [Full Text] [Related]  

  • 52. Absorption of warfarin from the stomach and small intestine.
    Pyörälä K; Jussila J; Mustala O; Siurala M
    Scand J Gastroenterol Suppl; 1971; 9():95-103. PubMed ID: 5284153
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacokinetics and excretion of hydroxysafflor yellow A, a potent neuroprotective agent from safflower, in rats and dogs.
    Chu D; Liu W; Huang Z; Liu S; Fu X; Liu K
    Planta Med; 2006 Apr; 72(5):418-23. PubMed ID: 16557455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stimulatory effect of benzo(alpha)pyrene and phenobarbital pretreatment on the biliary excretion of benzo(alpha)pyrene metabolites in the rat.
    Schlede E; Kuntzman R; Conney AH
    Cancer Res; 1970 Dec; 30(12):2898-904. PubMed ID: 5494574
    [No Abstract]   [Full Text] [Related]  

  • 55. Proceedings: Binding of warfarin on the serum proteins of mice and rats.
    Niedner R; von Oettingen U; Meyer F
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R70. PubMed ID: 4276623
    [No Abstract]   [Full Text] [Related]  

  • 56. Biliary excretion of moxicoumone in rats.
    Tajana A; Massarani E; Nardi D; Xamin E; Setnikar I
    Arzneimittelforschung; 1972 Mar; 22(3):539-42. PubMed ID: 5067926
    [No Abstract]   [Full Text] [Related]  

  • 57. Studies on the metabolism of cephalosporins. II. Biliary excretion and metabolism of 14 C-cephachlomezine and its parent compound.
    Okui M; Hattori K; Nidshida M
    J Antibiot (Tokyo); 1971 Oct; 24(10):667-74. PubMed ID: 5158582
    [No Abstract]   [Full Text] [Related]  

  • 58. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of selective and non-selective inbreeding on the rate of warfarin metabolism in the rat.
    Pyörälä K; Nevanlinna HR
    Ann Med Exp Biol Fenn; 1968; 46(1):35-44. PubMed ID: 5727660
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.